Post-Transplant Outcomes in Patients with Previously Treated Extrahepatic Malignancies Undergoing Living Donor Liver Transplantation

30 September 2025 : Original article

Amy Kim

^{BDEF 1}, Shin Hwang

^{ABCDEF 1*}, Chul-Soo Ahn

^{BDE 1}, Deok-Bog Moon

^{BCE 1}, Tae-Yong Ha

^{BCD 1}, Gi-Won Song

^{BCDF 1}, Dong-Hwan Jung

^{BCF 1}, Gil-Chun Park

^{BCD 1}, Woo-Hyoung Kang

^{BCD 1}, Young-In Yoon

^{BCD 1}, Sung-Gyu Lee

^{AEF 1}

DOI: 10.12659/AOT.949461

Ann Transplant 2025; 30:e949461

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 3 Cumulative rates of recurrence of pretransplant extrahepatic malignancies (EHM) in the 109 included patients.

Back to the Article